Challenges and advancements in the development of vaccines and therapies against Chagas disease | ||
| dc.conicet.organizacion | Drugs For Neglected Diseases Initiative | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni | |
| dc.conicet.organizacion | Drugs For Neglected Diseases Initiative | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni | |
| dc.conicet.organizacion | Hospital Israelita Albert Einstein | |
| dc.conicet.organizacion | Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais | |
| dc.conicet.organizacion | Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais | |
| dc.conicet.organizacion | Universidade Federal de Minas Gerais | |
| dc.contributor.author | Pinazo, Maria Jesus | |
| dc.contributor.author | Malchiodi, Emilio Luis | |
| dc.contributor.author | Ioset, Jean Robert | |
| dc.contributor.author | Bivona, Augusto Ernesto | |
| dc.contributor.author | Gollob, Kenneth J. | |
| dc.contributor.author | Dutra, Walderez O. | |
| dc.date.issued | 2024-10 | |
| dc.description.abstract | Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, presents a substantial global health burden, affecting millions of individuals worldwide and posing a continual risk of infection. Despite the high mortality and morbidity rates, effective vaccines to prevent infection by the parasite remain elusive, and the drugs currently available are suboptimal. Understanding the intricate dynamics of parasite–host interactions and the resulting immune responses, which contribute to both protection and pathology, is crucial for the development of effective vaccines and therapies against Chagas disease. In this Series paper, we discuss the challenges associated with discovering and translating prophylactic and therapeutic strategies from the laboratory bench to clinical application. We highlight ongoing efforts in vaccine and new drug development, with a focus on more advanced candidates for vaccines and drugs. We also discuss potential solutions, emphasising the importance of collaborative research efforts, sustained funding, and a comprehensive understanding of host–parasite interactions and immunopathology to advance the development of new vaccines and therapies against Chagas disease. | es |
| dc.description.fil | Fil: Pinazo, Maria Jesus. Drugs For Neglected Diseases Initiative; Brasil | |
| dc.description.fil | Fil: Malchiodi, Emilio Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina | |
| dc.description.fil | Fil: Ioset, Jean Robert. Drugs For Neglected Diseases Initiative; Suiza | |
| dc.description.fil | Fil: Bivona, Augusto Ernesto. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina | |
| dc.description.fil | Fil: Gollob, Kenneth J.. Hospital Israelita Albert Einstein; Brasil. Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais; Brasil | |
| dc.description.fil | Fil: Dutra, Walderez O.. Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais; Brasil. Universidade Federal de Minas Gerais; Brasil | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Pinazo, Maria Jesus; Malchiodi, Emilio Luis; Ioset, Jean Robert; Bivona, Augusto Ernesto; Gollob, Kenneth J.; et al.; Challenges and advancements in the development of vaccines and therapies against Chagas disease; Elsevier; The Lancet Microbe; 5; 10; 10-2024; 1-12 | es |
| dc.identifier.eissn | 2666-5247 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/263449 | |
| dc.journal.ciudad | Oxford | es |
| dc.journal.number | 10 | es |
| dc.journal.pagination | 1-12 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | The Lancet Microbe | es |
| dc.journal.volume | 5 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.lanmic.2024.100972 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2666524724002337 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ | * |
| dc.subject | TRYPANOSOMA CRUZI | es |
| dc.subject | CHAGAS DISEASE | es |
| dc.subject | VACCINE | es |
| dc.subject | BENZNIDAZOLE | es |
| dc.subject | VACCINE-LINKED CHEMOTHERAPY | es |
| dc.subject.classification | Enfermedades Infecciosas | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Challenges and advancements in the development of vaccines and therapies against Chagas disease | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.71b5df7a-7479-4baa-b6c2-56ed14468df1_B.pdf
- Tamaño:
- 549.62 KB
- Formato:
- Adobe Portable Document Format